HeartBeam Advances Cardiac Monitoring with Portable 12-Lead ECG System for Out-of-Hospital Use

Cardiac monitoring is evolving beyond the routine detection of abnormal heart rhythms toward a future where patients and physicians receive timely actionable insights that can guide clinical decisions outside of a healthcare facility. As healthcare increasingly emphasizes earlier intervention and more personalized care, HeartBeam (NASDAQ: BEAT) is developing technologies designed to transform where and how cardiac data are captured, analyzed and shared, including its proprietary, FDA-cleared HeartBeam System, the first portable, cable-free ECG system capable of synthesizing a 12-lead ECG for assessment of arrhythmias.

Advances in digital health, cloud computing and data analytics are making it possible to move beyond episodic monitoring toward a more comprehensive understanding of cardiovascular health. HeartBeam’s proprietary HeartBeam System reflects the company’s mission to make cardiac monitoring accessible beyond the walls of a medical facility. The synthesized 12-lead ECG view provided by the system can help clinicians evaluate rhythm abnormalities and identify rhythm changes that may warrant additional investigation.

For decades, cardiac monitoring has relied on the standard 12-lead ECG but its use has been confined to clinical settings, requiring bulky equipment, adhesive electrodes and trained personnel to administer. This means the most clinically meaningful cardiac data is only available in a doctor’s office or hospital. HeartBeam’s system addresses this limitation by providing a portable, cable-free solution that patients can use at home, potentially enabling earlier detection of cardiac events and reducing the need for in-person visits. The system’s ability to synthesize a 12-lead ECG from a simplified lead configuration could broaden access to advanced cardiac diagnostics, particularly for patients in remote or underserved areas.

By moving cardiac monitoring outside traditional clinical settings, HeartBeam aims to empower patients to take a more active role in their heart health while providing physicians with continuous data to inform treatment decisions. The implications of this technology extend beyond convenience; they could lead to reduced healthcare costs by preventing hospitalizations and enabling more efficient use of resources. As the healthcare industry continues to embrace digital health solutions, HeartBeam’s innovation represents a step toward a future where cardiac care is proactive rather than reactive.

For more information on HeartBeam and its technology, visit the company’s newsroom at https://ibn.fm/BEAT. See full terms of use and disclaimers on the InvestorBrandNetwork website at http://IBN.fm/Disclaimer.